| 1 |
29589062 | N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians. | 2018 Jul |
1 |
| 2 |
30564082 | Study of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit. | 2018 |
1 |
| 3 |
27223070 | Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population. | 2016 Jun 28 |
1 |
| 4 |
27509179 | Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2. | 2016 Dec |
2 |
| 5 |
27582327 | The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers. | 2016 |
1 |
| 6 |
26192006 | Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. | 2015 Oct |
1 |
| 7 |
26239303 | In-depth analysis of the critical genes and pathways in colorectal cancer. | 2015 Oct |
1 |
| 8 |
21480221 | Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study. | 2012 Mar 1 |
1 |
| 9 |
22686318 | N-Acetyltransferase 2 and glutathione s-transferase M1 in colon and rectal cancer cases from an industrialized area. | 2012 |
1 |
| 10 |
20801937 | N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population. | 2011 Jul |
1 |
| 11 |
21684175 | alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2. | 2011 Nov |
1 |
| 12 |
20723593 | Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man. | 2010 Oct 28 |
1 |
| 13 |
18704388 | Mesalazine pharmacokinetics and NAT2 phenotype. | 2009 Jan |
1 |
| 14 |
19082994 | Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected? | 2009 Apr |
5 |
| 15 |
19519341 | Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities. | 2009 May |
4 |
| 16 |
18569594 | N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany. | 2008 |
1 |
| 17 |
17011540 | Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay. | 2007 Feb |
2 |
| 18 |
17344941 | Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients. | 2007 Jan-Feb |
2 |
| 19 |
16003747 | NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. | 2006 Jan 1 |
1 |
| 20 |
16405939 | CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers. | 2006 Jun 15 |
1 |
| 21 |
16782969 | Stillbirth and slow metabolizers of caffeine: comparison by genotypes. | 2006 Aug |
2 |
| 22 |
16103443 | A phase I study of indole-3-carbinol in women: tolerability and effects. | 2005 Aug |
1 |
| 23 |
14747882 | Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure. | 2004 Mar |
8 |
| 24 |
14976127 | Low CYP1A2 activity associated with testicular cancer. | 2004 Jun |
1 |
| 25 |
15110095 | CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study. | 2004 Jun |
1 |
| 26 |
12580991 | Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug. | 2003 Feb |
1 |
| 27 |
11875368 | Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. | 2002 Mar |
1 |
| 28 |
12008149 | Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine. | 2002 May 15 |
1 |
| 29 |
12397635 | Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use. | 2002 Nov |
1 |
| 30 |
11292476 | Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping. | 2001 May 1 |
1 |
| 31 |
11393735 | Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment. | 2001 May 5 |
5 |
| 32 |
11603126 | N-acetyltransferase 2 phenotype in painters with bladder cancer and controls. | 2001 Sep |
1 |
| 33 |
10718779 | The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects. | 2000 Mar |
1 |
| 34 |
10027663 | Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. | 1999 Jan |
2 |
| 35 |
10744128 | Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. | 1999 Aug |
1 |
| 36 |
11253312 | [Phenotyping of cytochrome P-450 1A2 and N-acetyltransferase (NAT2) using the in vivo caffeine test as a tool for determining individual susceptibility to selected xenobiotics]. | 1999 |
2 |
| 37 |
9525538 | Rate of caffeine metabolism and risk of spontaneous abortion. | 1998 Mar 1 |
1 |
| 38 |
9565293 | Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy. | 1998 Apr |
1 |
| 39 |
9123684 | [Clinical relevance of acetylator phenotyping in 196 urothelial tumor patients]. | 1997 Jan |
1 |
| 40 |
9891107 | N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase ยต (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area. | 1997 Apr |
1 |
| 41 |
11596199 | [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities]. | 1997 Nov |
1 |
| 42 |
8689813 | N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus. | 1996 Jul |
1 |
| 43 |
8833625 | Correspondence re: S. H. McQuilkin et al., analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-Acetyltransferase-2 activities. Cancer Epidemiol., Biomarkers & Prev., 4: 139-146, 1995. | 1996 Mar |
1 |
| 44 |
8866914 | Caffeine as a metabolic probe: NAT2 phenotyping. | 1996 Mar |
3 |
| 45 |
8923605 | Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany. | 1996 Oct |
3 |
| 46 |
9156694 | Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. | 1996 Apr |
4 |
| 47 |
7586210 | Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity. | 1995 Nov |
1 |
| 48 |
7742721 | Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities. | 1995 Mar |
2 |
| 49 |
7828378 | Low CYP1A2 activity in rural Shona children of Zimbabwe. | 1995 Jan |
1 |
| 50 |
7920698 | Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity. | 1994 Jun |
1 |